Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Screening and Confirmatory diagnostic test for primary aldosteronism | Diagnostic Test | Screening for primary aldosteronism will be performed with measurement of aldosterone-to-renin ratio after 2 hours of bed rest. Renin measurement will be performed by estimating plasma renin activity. The screening test will be considered positive when the ratio is >30, accompanied by elevated aldosterone values (>15 ng/ml). Patients with a positive result will undergo further confirmatory testing with intravenous sodium test (administration 2 liters of normal saline N/S 0.9%, over a period of 4 hours, while the patient is supine. Considered positive if aldosterone levels are >5mg/dl at the end of the test). Alternative confirmatory methods are captopril test (Administration of 50 mg of captopril. Considered positive when aldosterone levels are >8.5 mg/dl 2 hours after the intake) or hydrocortisone test (Administration of 0.1mg of hydrocortisone 4 times a day for a period of 4 days. Considered positive if elevated aldosterone levels (>6ng/dl) are found at the end of the test). |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of primary aldosteronism in patients with atrial fibrillation | Percentage of patients with positive screening and confirmatory test for primary aldosteronism | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Association of marker of arterial stiffness with presence of primary aldosteronism in patients with atrial fibrillation | Pulse wave velocity | Baseline |
| Association of echocardiographic indices with presence of primary aldosteronism in patients with atrial fibrillation. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with atrial fibrillation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maria Toumpourleka, MSc | Contact | 00302310892343 | m.toumpourleka@gmail.com | |
| Vassilios P Vassilikos, PhD | Contact | 00302310892343 | vvassil@auth.gr |
| Name | Affiliation | Role |
|---|---|---|
| Maria Toumpourleka, MSc | Third Cardiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece | Principal Investigator |
| Vassilios P Vassilikos, PhD | Third Cardiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ippokratio General Hospital | Recruiting | Thessaloniki | 54642 | Greece |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D006929 | Hyperaldosteronism |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D008403 | Mass Screening |
| ID | Term |
|---|---|
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D006306 | Health Surveys |
| D011795 | Surveys and Questionnaires |
Not provided
Not provided
Not provided
Not provided
Not provided
Left ventricular global longitudinal strain (GLS) measured by transthoracic echocardiography |
| Baseline |
| Michael Doumas, PhD | Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece | Study Director |
| Christodoulos E Papadoupoulos | Third Cardiology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece | Study Chair |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D000308 | Adrenocortical Hyperfunction |
| D000307 | Adrenal Gland Diseases |
| D004700 | Endocrine System Diseases |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D003954 | Diagnostic Services |
| D011314 | Preventive Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
| D015980 | Public Health Practice |